Europe Is Probing Whether Ozempic Use Raises Risk of Suicidal Thoughts

📆 7/10/2023 9:30 PM
📰 WSJ

⏱ Reading Time:
26 sec. here
2 min. at publisher
📊 Quality Score:
News: 14%
Publisher: 63%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

European drug regulators are reviewing the risk of thoughts of suicide and self-harm in people taking Ozempic and another weight-loss drug after getting three reports

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.

https://www.wsj.com/articles/europe-is-probing-whether-ozempic-use-raises-risk-of-suicidal-thoughts-8c82533eShareDiabetes drugs could become an effective way to treat behavioral issues and addiction. WSJ’s Daniela Hernandez breaks down the science on how they work and how they could change psychiatry forever. Photo illustration: Elizabeth SmelovOzempic is under review by European drug-safety regulators after they received reports of suicidal thoughts linked to theDow Jones & Company, Inc.

Write Comment

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

EU probes Ozempic, weight-loss drug Saxenda after reports of suicidal thoughtsThe European Medicines Agency (EMA) is investigating Novo Nordisk's diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland's health regulator flagged three cases of patients thinking about suicide or self-harm.
Source: Reuters - 🏆 2. / 97 Read more »